| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2101057 | Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2010 | 11 Pages |
Abstract
T regulatory cells are able to suppress anti-tumour immunity in pre-clinical models and in patients. This review highlights the important discoveries in Treg immunology critical to the evolution of targeted immunotherapy. We also describe the therapeutic applications that are currently being assessed and their future potential.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Nizar, B. Meyer, C. Galustian, D. Kumar, A. Dalgleish,